Zentalis Pharmaceuticals Cash Flow Statement (2019-2026) | ZNTL

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-55.06M-10.49M-48.26M-57.49M-63.05M-52.13M-48.16M-60.95M-98.86M-55.54M-60.94M10.04M-88.28M-40.16M-47.47M-48.28M-26.87M-26.69M-35.22M-35.35M
Share-based Compensation (Quarter)
9.92M7.66M8.47M10.15M16.76M10.32M9.61M13.73M13.34M13.87M13.88M12.83M12.71M10.36M31.36M6.49M6.29M4.83M3.12M3.20M
Deferred Taxes (Quarter)
-0.07M0.07M-0.77M-0.10M-0.76M
Gains from Investment Securities (Quarter)
44.63M-0.06M0.12M-0.07M0.00M0.60M0.07M-0.05M0.53M0.10M-0.63M
Asset Writedowns and Impairment (Quarter)
-8.80M4.95M1.15M2.98M
Cash from Operations (Quarter)
-46.11M-33.49M-37.02M-50.20M-43.03M-33.20M-37.33M-49.28M-79.28M-38.66M-40.60M-51.97M-35.14M-44.05M-39.70M-32.64M-34.71M-26.96M-30.94M-32.96M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
3.70M
Amortizatization of Intangibles (Quarter)
0.23M-1.23M-0.20M-0.15M0.13M1.27M2.48M3.26M3.22M2.12M4.55M2.76M2.20M1.65M1.40M1.03M0.78M0.52M0.43M0.22M
Depreciation & Amortization (CF) (Quarter)
0.12M0.14M0.17M0.34M0.35M0.38M0.36M0.36M0.34M0.35M0.35M0.32M0.33M0.32M0.32M0.26M0.16M0.16M0.12M0.15M
Change in Working Capital
Change in Receivables (Quarter)
-0.24M0.10M-0.10M0.00M5.00M-5.00M
Change in Accured Expenses (Quarter)
1.53M7.47M1.65M-0.50M4.53M6.45M5.05M-1.41M-4.39M6.33M10.40M-15.25M11.80M-12.01M-2.56M-4.02M-10.58M-1.98M-0.73M-1.45M
Investing Activities
Capital Expenditures (Quarter)
-0.07M3.92M2.19M0.23M-0.14M2.30M0.16M0.32M0.09M0.17M0.04M0.18M0.03M
Sales of Property, Plant and Equipment (Quarter)
0.07M0.01M0.56M0.13M
Change in Acquisitions & Divestments (Quarter)
90.80M78.01M128.68M99.50M56.50M151.28M-307.28M106.00M198.46M146.75M54.10M71.70M54.00M74.00M71.50M60.00M70.00M-112.14M232.15M60.00M
Cash from Investing Activities (Quarter)
66.60M-141.44M43.27M19.80M-142.10M20.02M-11.89M42.12M72.93M-117.45M-42.06M61.55M34.49M48.24M32.28M40.48M30.38M28.32M32.45M30.01M
Financing Activities
Other financing activities (Quarter)
0.39M-0.39M0.24M
Change in Capital Stock
Shares Issued (Quarter)
4.03M167.94M1.26M184.30M-206.18M0.37M0.94M0.31M234.06M0.25M0.01M0.09M0.19M0.12M5.09M0.33M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
-0.32M166.57M12.27M1.26M209.46M0.59M49.74M0.37M236.62M0.31M0.01M0.01M0.09M0.19M0.12M-4.59M-1.12M
Change in Cash (Quarter)
20.17M-8.36M18.51M-29.14M24.33M-12.59M0.52M-6.79M230.28M-155.81M-82.66M9.58M-0.64M4.29M-7.42M8.03M-4.33M1.47M-3.08M-4.07M
Free Cash Flow (Quarter)
-46.05M-37.41M-39.21M-50.42M-42.89M-35.50M-37.49M-49.28M-79.59M-38.76M-40.77M-52.01M-35.32M-44.05M-39.70M-32.64M-34.71M-26.96M-30.94M-32.99M
Net Cash Flow (Quarter)
20.17M-8.36M18.51M-29.14M24.33M-12.59M0.52M-6.79M230.28M-155.81M-82.66M9.58M-0.64M4.29M-7.42M8.03M-4.33M1.47M-3.08M-4.07M